(Q44200949)

30 November 2017

Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death (English)

1 reference

30 November 2017

1 reference

1 reference

3

Carl Grunfeld

1 reference

30 November 2017

C Bradley Hare

1

1 reference

30 November 2017

Mai P Vu

series ordinal

2

1 reference

30 November 2017

Harry W Lampiris

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

25 October 2002

1 reference

Clinical Infectious Diseases

30 November 2017

1 reference

30 November 2017

35

1 reference

30 November 2017

10

1 reference

30 November 2017

e111-2

1 reference

FDA adverse event reports on statin-associated rhabdomyolysis

30 November 2017

1 reference

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations

21 January 2018

1 reference

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

21 January 2018

1 reference

HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein

21 January 2018

1 reference

Simvastatin and lovastatin, but not pravastatin, interact with MDR1.

21 January 2018

1 reference

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors

21 January 2018

1 reference

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

21 January 2018

1 reference

Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin

21 January 2018

1 reference

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus G

21 January 2018

1 reference

Rhabdomyolysis due to interaction of simvastatin with mibefradil

21 January 2018

1 reference

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

21 January 2018

1 reference

Pharmacokinetic enhancement of protease inhibitors.

21 January 2018

1 reference

Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/344179

1 reference

30 November 2017

1 reference